Complete hematologic remissions in chronic-phase, philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine
- 15 June 1994
- Vol. 73 (12) , 2953-2963
- https://doi.org/10.1002/1097-0142(19940615)73:12<2953::aid-cncr2820731212>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chronic myelogenous leukemia: a concise updateBlood, 1993
- Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupBlood, 1993
- Cladribine (2-chlorodeoxyadenosine)The Lancet, 1992
- Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected maleBlood, 1991
- Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1991
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986
- Chronic Myelogenous Leukemia — New ConceptsNew England Journal of Medicine, 1981
- Chronic Myelogenous Leukemia — New ConceptsNew England Journal of Medicine, 1981
- METAMORPHOSIS OF CHRONIC GRANULOCYTIC LEUKAEMIA: DIAGNOSIS, CLASSIFICATION, AND MANAGEMENTBritish Journal of Haematology, 1979